National Covid-19 Surveillance Physicians

• Conditions: Antibody COVID-19

• Registration Number: NCT04459312
• Lead Sponsor: Heinrich-Heine University, Duesseldorf

Brief Summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-06-01
• Status Verified: 2020-07
• Study First Submitted: 2020-07-03
• Study First Submitted QC: 2020-07-03
• Last Update Submitted: 2020-07-06
• Study First Posted: 2020-07-07
• Last Update Posted: 2020-07-08
• Primary Completion: 2020-07-10
• Study Completion: 2020-09-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• Qualified as physician

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence of antibodies against SARS-COV2	3 months

Trial Locations

Locations (1)

University Hospital Duesseldorf, Dept. of Anesthesiology; 🇩🇪 Duesseldorf, Germany